首页> 外文OA文献 >Clinical and Demographic Profile of Patients Receiving Fingolimod in Clinical Practice in Germany and the Benefit–Risk Profile of Fingolimod After 1 Year of Treatment: Initial Results From the Observational, Noninterventional Study PANGAEA

【2h】

Clinical and Demographic Profile of Patients Receiving Fingolimod in Clinical Practice in Germany and the Benefit–Risk Profile of Fingolimod After 1 Year of Treatment: Initial Results From the Observational, Noninterventional Study PANGAEA

机译：德国临床实践中患者患者的临床和人口统计学概况及佛教治疗后的菲林德益处风险概况：观察性，非行动研究术后的初始结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Tjalf Ziemssen; Michael Lang; Björn Tackenberg; Stephan Schmidt; Holger Albrecht; Luisa Klotz; Judith Haas; Christoph Lassek; Jennie Medin; Christian Cornelissen;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Clinical and Demographic Profile of Patients Receiving Fingolimod in Clinical Practice in Germany and the Benefit–Risk Profile of Fingolimod After 1 Year of Treatment: Initial Results From the Observational, Noninterventional Study PANGAEA [J] . Tjalf Ziemssen, Michael Lang, Bj?rn Tackenberg, Neurotherapeutics . 2018,第1期

机译：德国临床实践中接受芬戈莫德治疗的患者的临床和人口统计学资料以及治疗1年后芬戈莫德的获益-风险状况：观察性，非干预性研究PANGEA的初步结果
2. 36 months PANGAEA-A 5-year non-interventional study of safety, efficacy, and pharmacoeconomic data for fingolimod patients in daily clinical practice [J] . Ziemssen T., Albrecht H., Haas J., Multiple sclerosis: clinical and laboratory research . 2016,第6期

机译：为期36个月的PANGAEA-有关芬戈莫德患者日常临床实践中的安全性，有效性和药物经济学数据的5年非干预性研究
3. No evidence of disease activity in patients receiving fingolimod at private or academic centers in clinical practice: a retrospective analysis of the multiple sclerosis, clinical, and magnetic resonance imaging outcomes in the USA (MS-MRIUS) study [J] . Zivadinov Robert, Khan Nasreen, Korn Jonathan R., Current medical research and opinion . 2018,第8期

机译：没有证据临床实践中私人或学术中心接受Fingolimod患者的疾病活动：对美国（MS-MRIUS）研究的多发性硬化，临床和磁共振成像结果的回顾性分析
4. A Patient-Gene Model for Temporal Expression Profiles in Clinical Studies [C] . Naftali Kaminski, Ziv Bar-Joseph Annual International Conference on Research in Computational Molecular Biology(RECOMB 2006); 20060402-05; Venice(IT) . 2006

机译：临床研究中的时间表达谱的患者基因模型
5. A longitudinal cephalometric study evaluating the soft tissue profiles of patients treated with extraction mechanics 25 years post-treatment [D] . Bhavnani, Anita N. 2012

机译：一项纵向头颅测量研究，评估了治疗后25年接受拔牙力学治疗的患者的软组织特征
6. Clinical and Demographic Profile of Patients Receiving Fingolimod in Clinical Practice in Germany and the Benefit–Risk Profile of Fingolimod After 1 Year of Treatment: Initial Results From the Observational Noninterventional Study PANGAEA [O] . Tjalf Ziemssen, Michael Lang, Björn Tackenberg, 2018

机译：德国临床实践中接受芬戈莫德治疗的患者的临床和人口统计学资料以及治疗1年后芬戈莫德的受益风险风险谱：观察性非介入性研究PANGEA的初步结果
7. PRM20 Pangaea 2.0: State Of The Art Multiple Sclerosis Patient Management In Daily Clinical Practice. A New 3-Year Observational Study Of Patients Receiving Fingolimod [O] . Ziemssen T, Kern R, Cornelissen C 2015

机译：PRM20 Pangea 2.0：每日临床实践中最新的多发性硬化症患者管理。接受芬戈莫德治疗的患者的新三年观察研究

Clinical and Demographic Profile of Patients Receiving Fingolimod in Clinical Practice in Germany and the Benefit–Risk Profile of Fingolimod After 1 Year of Treatment: Initial Results From the Observational, Noninterventional Study PANGAEA

著录项

引文网络

相似文献

相关主题

期刊订阅